A61K 47/6883
Polymer-drug antibody conjugates
Official title: {Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy}
A61K47/6883 (Polymer-drug antibody conjugates) appears on 256 US grants and 407 published applications in this corpus.
Search patents in A61K- Granted patents
- 256
- Published applications
- 407
- Assignees
- 192
- Inventors
- 903
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 0 | 0 |
| 1991 | 7 | 0 |
| 1992 | 4 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 10 | 0 |
| 1997 | 7 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 4 |
| 2003 | 2 | 5 |
| 2004 | 0 | 1 |
| 2005 | 1 | 3 |
| 2006 | 1 | 5 |
| 2007 | 1 | 4 |
| 2008 | 0 | 3 |
| 2009 | 1 | 0 |
| 2010 | 1 | 6 |
| 2011 | 3 | 13 |
| 2012 | 3 | 3 |
| 2013 | 8 | 13 |
| 2014 | 10 | 11 |
| 2015 | 5 | 14 |
| 2016 | 5 | 28 |
| 2017 | 10 | 23 |
| 2018 | 12 | 30 |
| 2019 | 8 | 24 |
| 2020 | 14 | 26 |
| 2021 | 19 | 34 |
| 2022 | 16 | 38 |
| 2023 | 22 | 30 |
| 2024 | 20 | 37 |
| 2025 | 22 | 25 |
| 2026 | 16 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Controlled release of antibodies to modulate cytokines8 Sep 2026US 12,729,237 B2Flow Pharma, Inc.
- Rifamycin analogs and antibody-drug conjugates thereof25 Aug 2026US 12,715,881 B2Regeneron Pharmaceuticals, Inc.
- Methods and compositions for treating cancer with cancer-targeted adjuvants7 Jul 2026US 12,673,113 B2The University of Chicago
- Branched type hetero monodispersed polyethylene glycol, production method thereof, and conjugate thereof7 Jul 2026US 12,674,025 B2Nof Corporation
- Targeted dendrimer conjugates16 Jun 2026US 12,653,896 B2Starpharma Pty Limited
- Nanoparticle polymer encapsulation system3 Sep 2026US 2026/0256943 A1Core Quantum Technologies, Inc.
- Polymer Composite Nanomaterial Encapsulation System27 Aug 2026US 2026/0248954 A1Core Quantum Technologies, Inc.
- Improved linker-payloads for antibody conjugation, pharmaceutical compositions and applications thereof20 Aug 2026US 2026/0241021 A1Obi Pharma, Inc.
- Polymer-drug conjugates20 Aug 2026US 2026/0241029 A1Primelink Biotherapeutics (Shenzhen) Co., Ltd
- Fluorescent Emission Spectral Stacking of Polymer Encapsulated Quantum Dots6 Aug 2026US 2026/0224739 A1Core Quantum Technologies, Inc.
Most cited
By later US patents
- Tumoricidal methotrexate-antibody conjugate378US 4,699,784 ACenter for Molecular Medicine and Immunology · 1987
- Thioether conjugates293US 5,622,929 ABristol-Myers Squibb Company · 1997
- Diagnostic and therapeutic antibody conjugates285US 5,057,313 ACenter for Molecular Medicine and Immunology · 1991
- Immunological materials242US 4,046,722 AG. D. Searle & Co. · 1977
- Conjugates for introducing nucleic acid into higher eucaryotic cells213US 5,521,291 ABoehringer Ingelheim International GmbH · 1996